Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study

Table 4 Cox regression analysis of MACE in patients with DM, without DM and whole

Variable	Hazard Ratio	95% CI	SEM	P value
Whole
Hypertension	1.044	1.023 to 1.066	0.010	< 0.001
CKMB	0.993	0.989 to 0.997	0.002	0.002
FIB-L				0.033
FIB-M^a	1.797	1.117 to 2.892	0.243	0.016
FIB-H^a	1.664	1.002 to 2.763	0.259	0.049
DM
Hypertension	1.033	1.005 to 1.061	0.014	0.021
FIB-L				0.020
FIB-M^a	7.783	1.012 to 59.854	1.041	0.049
FIB-H^a	3.398	0.407 to 28.347	1.082	0.258
Non-DM
Hypertension	1.055	1.028 to 1.083	0.013	< 0.001
FIB-L				0.173
FIB-M^a	1.797	0.948 to 3.408	0.327	0.895
FIB-H^a	1.926	0.988 to 4.042	0.359	0.094

MACE major adverse cardiovascular events, FIB fibrinogen, CKMB creatine kinase isoenzymes MB, DM diabetes mellitus, CI confidence interval, SEM standard error of measurement
^aCompared with FIB-L group

ISSN: 1475-2840